Our patent attorneys are experts across a spectrum of technologies. Whether it is artificial intelligence, quantum computing, omics, or gene and protein engineering, we have the know-how to secure optimal protection for your inventions and support your growth. Having experience at the cutting edge of these technologies, combined with expertise and in-depth understanding of AI has meant that CMS is able to lead the way in providing advice in relation to computer-implemented inventions, including inventions at the interface of computing and life sciences. At CMS, we work collaboratively to make sure we understand your invention and can implement an effective patenting strategy for your commercial needs. We are experts on these considerations and are able to guide you when forming your patent strategy. We regularly assist with patent due diligence on AI acquisitions and provide training in AI ethics, AI regulation and AI standards. Being part of a full-service law firm also means that we can provide a single point of contact for other legal aspects of AI technologies, be it regulation, commercialization, licensing and other aspects.
Central to our AI team is CMS patent attorney and industry-wide recognised AI expert, Dr Rachel Free, who regularly advises clients on various aspects of patentability of AI and is one of the world’s leading specialists in the field. Rachel is a Vice-chair of the CIPA Computer Technology Committee and a member of All Party Parliamentary group on AI (APPG AI) and University of Bath Centre for Doctoral Training on Accountable, Responsible, Transparent AI.
AI Expertise
Technology Our AI patent work includes machine learning technology for data compression, new training algorithms, text prediction algorithms, constraint satisfaction technology, rule-based systems, robotics, explainable AI, scene understanding, AI accelerator hardware and AI security among others. The leading CMS patent team, integrating the patent prosecution team with litigators, is entrusted to protect research and development investments in Europe for Microsoft; handling in excess of 2000 live applications and prosecuting work with high-value, business critical stakes. “As a deep tech business, finding the right IP strategy is a fine line of protection vs sharing the secret sauce. CMS has been excellent at helping us identify how to protect our IP, carving out competitive advantage.” AI client, Skin Analytics We regularly assist clients with all aspects of AI intellectual property including freedom to operate, intellectual property audits and due diligence, invention harvesting, patent landscape analysis, novelty searching, advising on protection for inventions created using AI tools. | Life sciences and TechBio AI technology is increasingly used in the life sciences for a wide range of purposes including drug discovery, personalized medicine, dosage regimes, predicting drug interactions, interpreting x-ray crystallography results and more. At CMS we are extremely well placed to assist you with patent filing and prosecution in the life science AI field because we have individual team members with technical training as well as patent training in both life sciences and computer technology. Examples of our work in this area range from AI in biologics design and target selection to next-generation precision medicine using algorithms to process patient information e.g. biomarkers, and to pair with therapies or to determine risk factors for disease. We also regularly assist clients with the strategy related to achieving optimal protection for inventions created with the help of bioinformatics and AI methods. Our clients include companies at all stages of development – from seed funding rounds through to post-acquisition. |
